The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
Guo CJ, Leung PSC, Zhang W, Ma X, Gershwin ME.
Autoimmun Rev. 2018 Jan;17(1):78-85. doi: 10.1016/j.autrev.2017.11.012. Epub 2017 Nov 4.
The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review.
Yang Y, Jiang H, Yang W, Wang H, Wang M, Li X, Huang P, Fang S, Hao W, Yang Y, Zhao F, He W.
Front Immunol. 2025 Jan 7;15:1471115. doi: 10.3389/fimmu.2024.1471115. eCollection 2024.
Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
Liu Y, Wang F, Zhang L, Zhang H, Zhu Y.
BMC Pediatr. 2025 May 2;25(1):351. doi: 10.1186/s12887-025-05697-3.
Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I.
Oftedal BE, Marthinussen MC, Erichsen MM, Tveitarås MK, Kjellesvik-Kristiansen A, Hammenfors D, Jonsson MV, Kisand K, Jonsson R, Wolff ASB.
Autoimmunity. 2017 Jun;50(4):211-222. doi: 10.1080/08916934.2017.1344972. Epub 2017 Jul 7.
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.
N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.
Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review.
Zhao Z, Wang X, Bao XQ, Ning J, Shang M, Zhang D.
Cancer Immunol Immunother. 2021 Jun;70(6):1527-1540. doi: 10.1007/s00262-020-02699-1. Epub 2020 Nov 16.
Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.
Kämpe O.
J Intern Med. 2009 May;265(5):511-3. doi: 10.1111/j.1365-2796.2009.02094.x.
Delayed diagnosis of the full triad autoimmune polyendocrine syndrome type 2 with adrenal crisis: a case report and literature review.
Yao Z, Chen H, Hu X, Ge D, Xu X, Xu D.
Front Immunol. 2025 May 9;16:1563629. doi: 10.3389/fimmu.2025.1563629. eCollection 2025.
AIRE-mutations and autoimmune disease.
Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES.
Curr Opin Immunol. 2016 Dec;43:8-15. doi: 10.1016/j.coi.2016.07.003. Epub 2016 Aug 6.
Shock: A possible presenting manifestation of autoimmune polyendocrine syndrome type II.
Banzal S, Singhai A.
Indian J Crit Care Med. 2014 May;18(5):326-7. doi: 10.4103/0972-5229.132507.
